Andrius Žučenka, MD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania, discusses the challenges and advancements in treating acute myeloid leukemia (AML) in patients who are unfit for intensive…
Cristina Papayannidis, MD, PhD, University of Bologna, Bologna, Italy, discusses a study evaluating the efficacy of combining venetoclax with hypomethylating agents in treating patients with acute myeloid leukemia…
Researchers at the National University of Ireland Galway use biomaterials to protect neurons transplanted to the brain for the treatment of Parkinson’s disease.
A team of engineers are hoping the 12-sided cage they developed will one day help fight cancer. Made from self-assembling silica, the nanocage is only 11 nanometers across—for…
The gut microbiome is widely viewed as an exciting new treasure trove of medical insight. But the skin microbiome holds plenty of its own potential, including for patients…
Genetic testing for Parkinson’s risks can be useful to people with and without the disease. It can also help advance research into the complex condition. Although the testing…
A new study has refreshed decades-old statistical models for Parkinson’s disease, and in the process discovered that almost 1 million Americans will have the disease in 2020—more than…
